PBRM1-BD2-IN-3

CAS No. 2819989-58-5

PBRM1-BD2-IN-3( —— )

Catalog No. M35351 CAS No. 2819989-58-5

PBRM1-BD2-IN-3 (compound 12) is a potent PBRM1-BD2 inhibitor with an IC50 of 1.1 μM, used in anticancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 226 In Stock
5MG 256 In Stock
10MG 375 In Stock
25MG 562 In Stock
50MG 776 In Stock
100MG 1042 In Stock
200MG Get Quote In Stock
500MG 2102 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PBRM1-BD2-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    PBRM1-BD2-IN-3 (compound 12) is a potent PBRM1-BD2 inhibitor with an IC50 of 1.1 μM, used in anticancer research.
  • Description
    PBRM1-BD2-IN-3 (compound 12) is a potent PBRM1-BD2 inhibitor with an IC50 value of 1.1 μM. PBRM1-BD2 Inhibitor can be used to research anticancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    Epigenetic Reader Domain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2819989-58-5
  • Formula Weight
    258.7
  • Molecular Formula
    C14H11ClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2C(NC(N1)C3=CC=CC=C3)=CC=CC2Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shishodia S, et al. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. J Med Chem. 2022 Oct 13.?
molnova catalog
related products
  • GSK778

    GSK778 is a potent and selective inhibitor of BD1 bromodomain such as BRD2 BD1 (IC50s = 75 nM), BRD3 BD1 (IC50s = 41 nM), BRD4 BD1 (IC50s = 41 nM), and BRDT BD1 (IC50s = 143 nM). GSK778 inhibits proliferation, induces a cell cycle arrest and apoptosis.

  • WAY-309060

    WAY-309060 is a BRD4 small molecule inhibitor with antitumor activity.

  • ODM-207

    BET-IN-4 is a potent BRD4 inhibitor.